great point partners  private equity and public equity for growing health care companies – ceo advisory board – bernhard hampl phd skip navigation about great point partners for entrepreneurs for intermediaries team portfolio news careers contacts ceo advisory board managing directors principals senior vice presidents vice presidents  senior associates associates  analysts finance  administration investor relations ceo advisory board board members bernhard hampl phd darren head walter herlihy phd wayne langlois martin leblanc robert thomas donald tomasso bernhard hampl phd board member email dr bernhard hampl dr hampl joined great point partners’ advisory board in  and is cochairman of the board of directors of our portfolio companies cytovance biologics and softbox systems dr hampl is president of bkh pharmaservices llc and currently on the board of chenwerth inc a leading active pharmaceutical ingredient api provider to the pharmaceutical industry previously dr hampl was executive chairman of the board of app  fresenius kabi us from  to  he is also a minority investor in several startup pharmaceutical companies prior to that dr hampl was ceo of eon labs from  to  until the acquisition by novartis at which time he became the ceo of the sandoz usdivision of novartis during the period he was ceo of eon its revenue grew from  million to  million dr hampl earned a phd in pharmaceutical chemistry from the ludwig maximilian university of munich germany school of chemistry and pharmacy ceo experience sandoz usdivision of novartis – biosimilar biologic and generic pharmaceuticals eon labs – specialty pharmaceuticals previous profile next profile  great point partners site map home news legal disclosure investor portal search bernhard hampl phd elected to serve as executive chairman of the board of directors of fresenius kabi pharmaceuticals holding inc  business wire bernhard hampl phd elected to serve as executive chairman of the board of directors of fresenius kabi pharmaceuticals holding inc november    pm eastern standard time schaumburg illbusiness wirefresenius kabi pharmaceuticals holding inc nasdaq apcvz which acquired app pharmaceuticals inc september   today announced the election of bernhard hampl phd to its board of directors effective november   dr hampl also named as executive chairman of the board succeeds current chairman dr ulf m schneider dr schneider will continue to serve on the board of directors and as a member of the audit committee “dr hampl is one of the most experienced and wellrespected leaders in the generic pharmaceutical industry his addition to the board both strengthens and broadens the depth of our industry expertise” said dr schneider “i am confident that dr hampl is the right person to serve as executive chairman and know that he has the strategic and operational leadership experience that will allow us to capitalize on the opportunities before us i have been fortunate to have worked extensively in the generic pharmaceutical field and have witnessed many changes within our industry i am pleased to be joining the board of fresenius kabi pharmaceuticals holding and look forward to using my experience to expand app’s pipeline while exploring new opportunities that will position it for future growth said dr hampl dr hampl also serves as a member of the board of directors of chemwerth inc a private corporation and as an advisor to advent international corporation farmhispania and guidepoint global during his notable career dr hampl worked for  years for cyanamid gmbh and its business units lederle and durachemie gmbh where he held positions as director research and development technical director and plant director in  dr hampl joined hexal ag a leading manufacturer and marketer of generic pharmaceuticals in germany and led business development opportunities in the us generics market in october  hexal acquired  percent of eon labs inc and  percent ownership in  during this time dr hampl served as president and ceo in july  sandoz inc a division of novartis ag completed its merger with eon labs and dr hampl became the president and chief executive officer of sandoz inc the us operating unit of sandoz he resigned from sandoz effective september   while ceo of sandoz dr hampl also served as a member of the executive board of the generic pharmaceutical association he received his phd in pharmaceutical chemistry from ludwigmaximillians university in munich germany about app pharmaceuticals inc app pharmaceuticals inc is a fullyintegrated pharmaceutical company that develops manufactures and markets injectable pharmaceutical products with a primary focus on the oncology antiinfective anestheticanalgesic and critical care markets the company offers one of the most comprehensive product portfolios used in hospitals longterm care facilities alternate care sites and clinics within north america and manufactures a comprehensive range of dosage formulations fresenius kabi pharmaceuticals holding inc a wholly owned subsidiary of fresenius kabi ag acquired app pharmaceuticals inc on september   for more information about app pharmaceuticals inc please visit the company’s web site at wwwapppharmacom about fresenius kabi ag fresenius kabi ag is the leader in infusion therapy and clinical nutrition in europe and in its most important countries of latin america and asia pacific fresenius kabi’s core product range includes infusion solutions for fluid substitution blood volume expansion iv drugs and parenteral nutrition as well as products for enteral nutrition furthermore the company provides concepts for ambulatory health care and is focused on managing and providing home therapies with the philosophy “caring for life” and a comprehensive product portfolio the company aims at improving the quality of life of patients all over the world in  fresenius kabi achieved sales of eur  million and an operating profit of eur  million for more information visit the company’s web site at wwwfreseniuskabicom fresenius kabi ag is a  subsidiary of fresenius se about fresenius se fresenius se is a health care group with international operations providing products and services for dialysis hospital and outpatient medical care in  group sales were approximately eur  billion on june   the fresenius group had  employees worldwide for more information visit the company’s web site at wwwfreseniuscom forwardlooking statement the statements contained in this news release that are not purely historical are forwardlooking statements within the meaning of section e of the securities exchange act of  as amended forwardlooking statements in this news release include statements regarding our expectations beliefs hopes goals intentions initiatives or strategies including statements regarding the demand supply and distribution of our products because these forwardlooking statements involve risks and uncertainties there are important factors that could cause actual results to differ materially from those in the forwardlooking statements these factors include but are not limited to the availability and pricing of ingredients used in the manufacture of pharmaceutical products and the ability to successfully manufacture products in a timesensitive and cost effective manner additional relevant information concerning risks can be found in the fresenius kabi pharmaceuticals holding inc k for the fiscal year ending december   and other documents the company has filed with the securities and exchange commission the information contained in this news release is as of the date of this release fresenius kabi pharmaceuticals holding inc does not assume any obligation to update or revise these forwardlooking statements to conform the statement to actual results new information developments or changes in the company’s expectations contacts app contactapp pharmaceuticals incdebra lynn rossdirector corporate communicationsdrossapppharmacomorinvestor inquirieshill  knowltonchristine cassianochristinecassianohillandknowltoncom contacts app contactapp pharmaceuticals incdebra lynn rossdirector corporate communicationsdrossapppharmacomorinvestor inquirieshill  knowltonchristine cassianochristinecassianohillandknowltoncom search advanced news search advanced news search log in sign up insider trading  hampl bernard dr  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  hampl bernard dr select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana cambrex corp cbm hampl bernard drdirector   direct view option award  pm  cambrex corp cbm hampl bernard drdirector   direct view   secformcom all rights reserved archives        sun  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  bernhard hampl phd executive profile  biography  bloomberg july    pm et capital markets company overview of advent international corporation snapshotpeople  overviewboard memberscommittees executive profile bernhard hampl phdindustry advisor advent international corporationagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr bernhard hampl phd serves as president of bkh pharmaservices dr hampl is an industry advisor to advent international corporation dr hampl serves as an advisor to farmhispania and guidepoint global he advises companies from the field of pharmaceuticals and biotechnology as well as investment companies he is also a minority investor in several startup pharmaceutical companies he served as the chief executive officer at eon labs inc from october   to  and its president since january  during the period he served as the chief executive officer of eon he served as the chief executive officer of the sandoz usdivision and head of sandoz operations  us region at novartis ag he served as the chief executive officer and president of sandoz inc from july  to  he was responsible for all united states operations for sandoz he served on hexal ag to evaluate the possibility of establishing a united states subsidiary from may  to october  during this time he served as the president and chief executive officer at hexal ag he served as department head of research and development of cyanamid gmbh and its business unit lederle and durachemie gmbh where he was responsible for research and development activities in germany for the medical agricultural and veterinary business of cyanamid gmbh and from april  to may  as its technical director he serves as an executive chairman of the board of appfresenius he has been a cochairman of the board of softbox systems ltd since july   dr hampl serves as a member of the board of directors of chemwerth inc and uconn ventures dr hampl has been a director of cambrex corporation since october   he has been a member of chief executive officer advisory board at great point partners llc since  he serves as a director of sio medical he has been a member of advisory board at formycon ag since march   he served as cochairman of the board of directors at cytovance biologics inc he served as an executive chairman of fresenius kabi pharmaceuticals holding inc from november  to february   he served as a director of fresenius kabi pharmaceuticals holding inc from november  to february   he served as a member of the board of directors at the generic pharmaceutical association gpha he has wideranging international experience dr hampl has over  years of experience in the pharmaceutical industry leading companies competing within the generic and branded drug space dr hampl holds bachelor degree in pharmaceutical sciences and a phd in pharmaceutical chemistry from ludwig maximillian university of munich germany school of pharmacyread full background corporate headquarters  state streetboston massachusetts united statesphone fax  board members memberships cochairman of the boardsoftbox systems ltdpresentdirectorcambrex corporation education phd ludwigmaximiliansuniversität münchenbachelors degree ludwigmaximiliansuniversität münchen other affiliations fresenius kabi pharmaceuticals holding inceon labs inccambrex corporationnovartis agludwigmaximiliansuniversität münchengreat point partners llcassociation for accessible medicinessandoz international gmbhcytovance biologics incformycon agsoftbox systems ltd annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact advent international corporation please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bernard dr hampl  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors bernard dr hampl check out list of companies and businesses related to bernard dr hampl find out bernard dr hampl address and contact details view other people related to bernard dr hampl  coworkers colleagues companions etc address  north conduit avenue laurelton  ny companies related to bernard dr hampl cikcompany namepositioncompany addresscambrex corpdirector one meadowlands plaza e rutherford eon labs incpresident and ceo  seventh ave new york  bernard dr hampl on the web persons related to bernard dr hampl  cambrex corpnamepositioncitygupta anupvice president east rutherfordluke m besharexecutive vice president east rutherfordluke m besharevp  cfo east rutherforddavid r bethunedirector east rutherfordthomas n birdformer vice president east rutherfordthomas n birdvp corporate development east rutherfordronnie d carrollvice president east rutherfordronnie d carrollvp  cto east rutherfordshawn cavanaghevp  coo east rutherfordrobert j congiustivice president east rutherfordrosina b dixondirector rosina b dixondirector east rutherfordn david eansor east rutherfordn david eansorpresident bioproducts east rutherfordclaes glasselldirector concordlouis j grabowskydirector new yorksalvatore j guccione srexecutive vice president east rutherfordroy w haleydirector east rutherfordbernard dr hampldirector laureltonsamantha hanleyvp general counsel east rutherfordkathryn harrigandirector east rutherfordkathryn harrigandirector east rutherfordkathryn harrigandirector east rutherfordkathryn harrigandirector east rutherfordwilliam m haskelsenior vice president east rutherfordwilliam m haskelsenior vice president east rutherfordleon j hendrix jrdirector leon j hendrix jrdirector east rutherfordleon j hendrix jrdirector east rutherfordilan kaufthaldirector east rutherfordtlan kaufthaldirector east rutherfordsteven m kloskpresident  ceo east rutherfordsteven m kloskpresident  ceo east rutherfordwilliam b korbdirector east rutherfordrobert lebuhndirector east rutherfordjohn r leonepresident  ceo east rutherfordjohn r leonepresident  ceo east rutherfordjames a mackpresident ceo  chairman east rutherfordaldo magninimanaging director profarmaco east rutherforddaniel r marshakvice president east rutherforddaniel r marshakvp  cto east rutherfordjohn r millerdirector east rutherfordjohn r millerdirector east rutherfordgary l mossmanformer evp  coo east rutherfordpaolo russolopresident cambrex profarmaco east rutherfordpaolo russolopresident cambrex profarmaco east rutherfordpaolo russolo east rutherfordgregory sargenevp corporate development east rutherfordpeter e thauser srsenior vice president east rutherfordpeter e thauser srsvp law gen counsel corp sec east rutherfordpeter e thauser srsenior vice president east rutherfordpeter g tombrosdirector east rutherfordpeter g tombrosdirector east rutherford nj tom george vadakethexecutive vice president  cfo east rutherfordhoorn peter van east rutherfordjames f winschel jrdirector east rutherfordshlomo yanaidirector east rutherfordf michael zacharavice president east rutherfordpersons related to bernard dr hampl  eon labs incnamepositioncityjeffrey s bauervice president business dev laureltonjeffrey s bauervp business development laureltonjeffrey s bauervp business development lake successfrank f beelitzdirector laureltonfrank f beelitzdirector laureltonfrank f beelitzlaureltonfrank f beelitzdirector lake successdr pranab bhattacharyyavp qual mgmt  analyical svs laureltondr pranab bhattacharyyavp quality mgmt  anlytc ser lake successsadie ciganekvp regulatory affairs laureltonsadie ciganekvp regulatory affairs lake successfera frank j dellavp sales and marketing laureltonfera frank j dellavp sales and marketing laureltonfera frank j dellavp sales  marketing lake successwilliam b eversgerdvp plant facilities laureltonwilliam b eversgerdvp plant facilities laureltonwilliam b eversgerdvice pres plant facilities lake successdavid h granseecontroller  asst secretary laureltondavid h granseecontroller  asst secretary laureltondavid h granseecontroller  asst secretary laureltondavid h granseecontroller  asst secretary lake successbernard dr hamplpresident and ceo laureltonbernard dr hamplpresident and ceo laureltonbernard dr hamplpresident and ceo laureltonbernard dr hamplpresident  ceo lake successwilliam f holtvp fin secy treas  cfo laureltonwilliam f holtvp fin sec treas  cfo lake successdouglas m karpdirector laureltondouglas m karpdirector lake successrathnam kumarvp manufacturing laureltonrathnam kumarvice president marketing lake successag novartisbasel switzerlandnovartis corpnew yorkmark r pattersondirector laureltonmark r pattersondirector lake successdr leon shargelvp biopharmaceutics laureltondr leon shargelvp biopharmaceuticals lake successnitin v shethvp research  development laureltonthomas dr strungmanndirector  holzkirchen germanythomas dr strungmanndirector berlinshashank upadhyelaureltonshashank upadhyevice president and counsel laureltonshashank upadhyevp and general counsel lake success bernhard hampl  sandoz inc  zoominfocom secgems hampl bernhard data feeds now available excel  csv  java  python etc database learn more hampl bernhard info ownership filings  eon labs inc  n conduit ave laurelton  ny   usa  filing datecurrent and former nameschanged on date hampl bernhard hampl bernard dr central index key cik  ownership form  filings hampl bernard dr   all related personscompanies filings cambrex corp   eon labs inc   hampl bernard dr   db access denied access denied you dont have permission to access httphealthusnewscomdoctorsorihampel on this server reference  access denied access denied you dont have permission to access httphealthusnewscomdoctorsorihampel on this server reference